[go: up one dir, main page]

UY25407A1 - Método para la síntesis de (-)-(s)-n-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida - Google Patents

Método para la síntesis de (-)-(s)-n-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida

Info

Publication number
UY25407A1
UY25407A1 UY25407A UY25407A UY25407A1 UY 25407 A1 UY25407 A1 UY 25407A1 UY 25407 A UY25407 A UY 25407A UY 25407 A UY25407 A UY 25407A UY 25407 A1 UY25407 A1 UY 25407A1
Authority
UY
Uruguay
Prior art keywords
phenylquinoline
hydroxy
reaction mixture
ethylbenzyl
carboxamide
Prior art date
Application number
UY25407A
Other languages
English (en)
Inventor
Joseph Sisko
Mark Mellinger
Conrad Kowalski
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of UY25407A1 publication Critical patent/UY25407A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Procedimiento para preparar (-)-(S)-N-(alfa-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida, que comprende: 1) hacer reaccionar ácido 3-hidroxi-2-fenilquinolina-4-carboxílico, en un disolvente adecuado, con trietilamina, para formar una primera mezcla de reacción, enfriar la primera mezcla de reacción, y añadir cloruro de tionilo para formar una segunda mezcla de reacción que comprende 6,14,22,30-tetrafenil-[1,5,9,13]tetraoxahexadecino [2,3-c:6,7-c':10,11-c":14,15-c'"]tetraquinolina-8,16,21,32-tetrona y 3-cetoxi-2-fenilquinolina-4-carboxilato de etilo; 2) añadir (S)-1-fenil-propilamina a la segunda mezcla de reacción para formar una tercera mezcla de reacción que comprende (-)-(S)-N-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida y 3-hidroxi-2-fenil-4-quinolinacarboxilato de (S)-2-fenil-4-[[(1-fenilpropil)amino]carbonil-3-quinolinilo; 3)calentar la tercera mezcla de reacción; y 4)opcionalmente convertir (-)-(S)-N-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida en una sal farmacéuticamnete aceptable.
UY25407A 1997-09-17 1999-02-26 Método para la síntesis de (-)-(s)-n-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida UY25407A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5930397P 1997-09-17 1997-09-17
UY25174A UY25174A1 (es) 1997-09-17 1998-09-08 Método para la síntesis de derivados de quinolina

Publications (1)

Publication Number Publication Date
UY25407A1 true UY25407A1 (es) 1999-11-17

Family

ID=22022126

Family Applications (2)

Application Number Title Priority Date Filing Date
UY25174A UY25174A1 (es) 1997-09-17 1998-09-08 Método para la síntesis de derivados de quinolina
UY25407A UY25407A1 (es) 1997-09-17 1999-02-26 Método para la síntesis de (-)-(s)-n-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY25174A UY25174A1 (es) 1997-09-17 1998-09-08 Método para la síntesis de derivados de quinolina

Country Status (32)

Country Link
US (6) US6335448B1 (es)
EP (1) EP1017676B1 (es)
JP (1) JP2001516744A (es)
KR (1) KR20010024031A (es)
CN (1) CN1125815C (es)
AP (1) AP1201A (es)
AR (1) AR015445A1 (es)
AT (1) ATE353879T1 (es)
AU (1) AU744538B2 (es)
BG (1) BG104243A (es)
BR (1) BR9812085A (es)
CA (1) CA2303026A1 (es)
DE (1) DE69837100T2 (es)
DZ (1) DZ2607A1 (es)
EA (1) EA002633B1 (es)
ES (1) ES2283072T3 (es)
HU (1) HUP0004855A3 (es)
ID (1) ID24140A (es)
IL (1) IL134991A0 (es)
MA (1) MA24644A1 (es)
MY (1) MY120237A (es)
NO (1) NO314303B1 (es)
NZ (1) NZ503307A (es)
OA (1) OA11340A (es)
PE (1) PE129299A1 (es)
PL (1) PL339340A1 (es)
SK (1) SK3672000A3 (es)
TR (1) TR200000720T2 (es)
TW (1) TW509678B (es)
UY (2) UY25174A1 (es)
WO (1) WO1999014196A1 (es)
ZA (1) ZA988455B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.
AU4038600A (en) 1999-03-29 2000-10-16 Neurogen Corporation 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
EA010369B1 (ru) 2004-02-04 2008-08-29 Пфайзер Продактс Инк. Замещенные хинолиновые соединения
CN101189211A (zh) * 2005-06-03 2008-05-28 阿斯利康(瑞典)有限公司 作为nk3拮抗剂的喹啉衍生物
JP2009504572A (ja) * 2005-08-02 2009-02-05 スミスクライン・ビーチャム・コーポレイション キノリン誘導体の合成方法
EP1915363A1 (en) * 2005-08-11 2008-04-30 AstraZeneca AB Oxopyridyl quinoline amides as nk3 receptor modulators
EP1940795A1 (en) * 2005-09-21 2008-07-09 AstraZeneca AB N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands
AR057130A1 (es) * 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
WO2007086799A1 (en) * 2006-01-27 2007-08-02 Astrazeneca Ab Amide substituted quinolines
CN102924375B (zh) * 2012-06-21 2015-02-18 江苏恩华药业股份有限公司 Talnetant中间体及其制备方法和应用
CN102702099A (zh) * 2012-06-21 2012-10-03 江苏恩华药业股份有限公司 (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法
CN103214416A (zh) * 2013-04-26 2013-07-24 扬州大学 一种合成多取代喹啉类化合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776290A (en) * 1957-01-01 Hydroxy cevchoninates and carboxylic
DE69533408T2 (de) * 1994-05-27 2005-09-08 Glaxosmithkline S.P.A. Chinolinderivate als Tachykinin NK3 Rezeptor Antagonisten
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.

Also Published As

Publication number Publication date
DE69837100D1 (de) 2007-03-29
WO1999014196A1 (en) 1999-03-25
AU9395898A (en) 1999-04-05
BR9812085A (pt) 2000-09-26
UY25174A1 (es) 2001-07-31
EP1017676A4 (en) 2002-12-04
TR200000720T2 (tr) 2000-08-21
JP2001516744A (ja) 2001-10-02
PE129299A1 (es) 2000-02-19
NO314303B1 (no) 2003-03-03
HUP0004855A2 (hu) 2001-06-28
US20020038029A1 (en) 2002-03-28
EA200000322A1 (ru) 2000-10-30
KR20010024031A (ko) 2001-03-26
NZ503307A (en) 2002-04-26
NO20001387D0 (no) 2000-03-16
SK3672000A3 (en) 2000-09-12
MY120237A (en) 2005-09-30
US20060189809A1 (en) 2006-08-24
AP2000001767A0 (en) 2000-03-31
US6335448B1 (en) 2002-01-01
OA11340A (en) 2003-12-09
AP1201A (en) 2003-09-01
HUP0004855A3 (en) 2001-08-28
EP1017676A1 (en) 2000-07-12
US20020173657A1 (en) 2002-11-21
CN1278796A (zh) 2001-01-03
PL339340A1 (en) 2000-12-18
US20050171152A1 (en) 2005-08-04
ZA988455B (en) 1999-02-17
ES2283072T3 (es) 2007-10-16
US20040049031A1 (en) 2004-03-11
ID24140A (id) 2000-07-06
AU744538B2 (en) 2002-02-28
DE69837100T2 (de) 2007-11-22
ATE353879T1 (de) 2007-03-15
EP1017676B1 (en) 2007-02-14
AR015445A1 (es) 2001-05-02
NO20001387L (no) 2000-03-16
EA002633B1 (ru) 2002-08-29
CA2303026A1 (en) 1999-03-25
DZ2607A1 (fr) 2003-03-01
CN1125815C (zh) 2003-10-29
BG104243A (en) 2001-05-31
TW509678B (en) 2002-11-11
MA24644A1 (fr) 1999-04-01
IL134991A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
UY25407A1 (es) Método para la síntesis de (-)-(s)-n-(alpha-etilbencil)-3-hidroxi-2-fenilquinolina-4-carboxamida
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
CA2203936A1 (en) Boronic ester and acid compounds, synthesis and uses
MA18664A1 (fr) Derives d'amino-acides utiles comme agents contre l'hypertension
BR0015471A (pt) Método para preparação de 5-carboxiftalida
DE69805926D1 (de) Verfahren zur Herstellung von Sevoflurane
NO895002L (no) Enzymhemmende aminosyrederivater.
BR0009518A (pt) Processo para a preparação de um éster do ácido 2-hidroxi-4-metiltiobutìrico
JPS57109797A (en) Preparation of low-molecular weight keratinous substance
AU3042497A (en) Vaccine containing a peroxiredoxin and/or a beta-tubulin
CA2390296A1 (en) Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
EE9700263A (et) Klavulaanhappe soolade valmistamine
EA199600007A2 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
DE3364027D1 (en) N-(2-(4-hydroxy-3-methoxy-phenyl)-2-hydroxy-ethyl)-3-amino-1(1-benzimidazolyl) butane and salts and hydrates with beta-adrenergic activity, therapeutical applications and process for their preparation
EA200000410A3 (ru) Способ получения (1r,2s,4r)-(-)-2-[(2'-{n,n-диметиламино}-этокси)]-2-[фенил]-1,7,7,-три-[метил]-бицикло(2,2,1) гептана и его фармацевтически приемлемых кислотных аддитивных солей
CO4950550A1 (es) Procedimiento
DE3465297D1 (en) Derivatives of n-(methoxyphenacyl)amine, their therapeutical use and process for their preparation
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
DE69907725D1 (de) Verbesserung der follikelgenese
BR9913249A (pt) Processo para a produção de um ácido 2-azetidina carboxìlico n-protegido, e, produto
MX9704836A (es) Proceso para la fabricaciom de acetonilbenzamidas.
JPS55130949A (en) Novel phenylacetamide derivative
ATE295728T1 (de) Herstellung von 3-fluoroxindolderivaten
TH21261A (th) "กระบวนการสำหรับเตรียม ( 1-ไฮดรอกซีไซโคลเฮกเซน) อาซีโตไนตริล"
AU2939700A (en) Synthesis of alpha-amino-alpha',alpha'-dihaloketones and process for the preparation of beta-amino acid derivatives by the use of the same

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20071105